Insiders Trades
Integrated Biopharma Inc Stock: price and insider trades · United States
Integrated Biopharma Inc: what insiders have been doing
Integrated Biopharma Inc, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). From 18 October 2025 to 18 October 2026, the disclosure feed for Integrated Biopharma Inc logged 11 filings by 3 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
No insider has bought Integrated Biopharma Inc shares on the open market in the past twelve months. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4.
Across the 5,808 companies tracked on its exchange, the median is 19 filings; at 11 filings, this issuer sits below that mark.
Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
25
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 4,929 of 24,148 companies
66.6
score / 100
Value97
Quality36
FCF yld37%
Earn yld16%
EV/EBITDA1.8x
ROE-8.4%
Gross mgn10%
Net mgn1.5%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended June 2025 · cache
US$0.16
Analyst consensus
4 analysts1.50/5
US$40.00Target US$61.00(+38025%)US$74.00
Income statement
RevenueUS$54.4M
Gross profitUS$5.6M10% margin
EBITDAUS$3.3M6% margin
Net incomeUS$808k-3.4% margin
Valuation
PER (trailing)13.7x
PER (forward)9.6x
P/Book0.3x
Beta0.38
Balance sheet & cash
Market capUS$5M
Total debtUS$1M
Free Cash FlowUS$1.9M
Debt / Equity18%
Profitability & ownership
ROE-8.4%
ROA-3.0%
% insiders68.4%
% institutions0.1%
Last declaration on 17 April 2026
Declarations25 total
8,966,547 shares0Common StockSEC:0001102948-26-000002:0
8,966,547 shares0Common StockSEC:0001345281-26-000004:0
2,235,417 shares0Common StockSEC:0001345281-26-000004:1
8,966,547 shares0Common StockSEC:0001443194-26-000004:0
2,235,417 shares0Common StockSEC:0001443194-26-000004:1
8,966,547 shares0Common StockSEC:0001443194-26-000005:0
2,235,417 shares0Common StockSEC:0001102948-26-000002:1
2,235,417 shares0Common StockSEC:0001443194-26-000005:1
1,356,293 shares0Common StockSEC:0001102948-26-000001:0
1,356,293 shares0Common StockSEC:0001443194-26-000003:0
1,356,293 shares0Common StockSEC:0001345281-26-000001:0
50,000 shares@ US$0.09100.0% of flowCommon StockSEC:0001345281-25-000005:0
144,445 shares@ US$0.090.9% of flowCommon StockSEC:0001345281-25-000003:0
175,000 shares@ US$0.09100.0% of flowCommon StockSEC:0001345281-25-000001:0
144,445 shares@ US$0.090.9% of flowCommon StockSEC:0001345281-25-000004:0
55,555 shares@ US$0.090.4% of flowCommon StockSEC:0001345281-24-000006:0
55,555 shares@ US$0.090.4% of flowCommon StockSEC:0001064900-24-000001:0
3,410,512 shares@ US$0.4097.5% of flowCommon StockSEC:0001064900-23-000002:0
3,410,512 shares@ US$0.4097.5% of flowCommon StockSEC:0001064901-23-000002:0
50,000 shares@ US$0.341.2% of flowCommon StockSEC:0001064901-23-000001:0
50,000 shares@ US$0.341.2% of flowCommon StockSEC:0001064900-23-000001:0
100,000 shares@ US$0.23100.0% of flowCommon StockSEC:0001053310-22-000001:0
25 of 25 declarations
About Integrated Biopharma Inc
Integrated Biopharma Inc is a company focused on the health and pharmaceutical sector. It is listed on the XNAS market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
